105 related articles for article (PubMed ID: 35422382)
1. Early-onset pancreatic cancer: Clinical characteristics and survival outcomes.
Takeda T; Sasaki T; Inoue Y; Okamoto T; Mori C; Mie T; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Takahashi Y; Saiura A; Sasahira N
Pancreatology; 2022 May; 22(4):507-515. PubMed ID: 35422382
[TBL] [Abstract][Full Text] [Related]
2. Early-onset pancreatic cancer: a population-based study using the SEER registry.
Ansari D; Althini C; Ohlsson H; Andersson R
Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
[TBL] [Abstract][Full Text] [Related]
3. Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival.
Ulanja MB; Moody AE; Beutler BD; Antwi-Amoabeng D; Rahman GA; Alese OB
Oncotarget; 2022; 13():828-841. PubMed ID: 35720978
[TBL] [Abstract][Full Text] [Related]
4. Demographic, clinical, and pathological features of early onset pancreatic cancer patients.
Ntala C; Debernardi S; Feakins RM; Crnogorac-Jurcevic T
BMC Gastroenterol; 2018 Sep; 18(1):139. PubMed ID: 30208959
[TBL] [Abstract][Full Text] [Related]
5. Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature.
Whitley A; Kocián P; Nikov A; Krejčí D; Pehalová L; Blaha M; Dušek L; Gürlich R
J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1324-1333. PubMed ID: 37750364
[TBL] [Abstract][Full Text] [Related]
6. Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resection.
Zironda A; Zhang C; Day C; McWilliams RR; Starlinger P; Warner SG; Smoot RL; Cleary SP; Kendrick ML; Truty MJ; Thiels CA
HPB (Oxford); 2024 Jan; 26(1):145-153. PubMed ID: 37752029
[TBL] [Abstract][Full Text] [Related]
7. Early onset pancreatic cancer: risk factors, presentation and outcome.
Piciucchi M; Capurso G; Valente R; Larghi A; Archibugi L; Signoretti M; Stigliano S; Zerboni G; Barucca V; La Torre M; Cavallini M; Costamagna G; Marchetti P; Ziparo V; Delle Fave G
Pancreatology; 2015; 15(2):151-5. PubMed ID: 25708929
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics, treatment patterns and survival outcomes of early-onset pancreatic adenocarcinoma: a population-based study.
Ren S; Sadula A; Ye C; Chen Q; Yuan M; Meng M; Lei J; Li G; Yuan C
Am J Transl Res; 2023; 15(1):407-421. PubMed ID: 36777821
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns and survival in patients with early-onset pancreatic cancer.
Saadat LV; Chou JF; Gonen M; Soares KC; Kingham TP; Varghese AM; Jarnagin WR; D'Angelica MI; Drebin JA; O'Reilly EM; Wei AC
Cancer; 2021 Oct; 127(19):3566-3578. PubMed ID: 34228820
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genomic characterisation of early-onset pancreatic cancer.
Castet F; Fabregat-Franco C; Castillo G; Navarro V; Sierra A; Acosta DA; López-Valbuena D; Dienstmann R; Tabernero J; Vivancos A; Tian TV; Macarulla T
Eur J Cancer; 2023 Nov; 194():113338. PubMed ID: 37793216
[TBL] [Abstract][Full Text] [Related]
11. Resected Early-Onset Pancreatic Cancer: Practices and Outcomes in an International Dual-Center Study.
Leonhardt CS; Kinny-Köster B; Hank T; Habib JR; Shoucair S; Klaiber U; Cameron JL; Hackert T; Wolfgang CL; Büchler MW; He J; Strobel O
Ann Surg Oncol; 2023 Apr; 30(4):2433-2443. PubMed ID: 36479659
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive comparison of clinicopathological characteristics, treatment, and prognosis of borderline resectable pancreatic cancer according to tumor location.
Takeda T; Sasaki T; Inoue Y; Mie T; Furukawa T; Kanata R; Kasuga A; Matsuyama M; Ozaka M; Takahashi Y; Saiura A; Sasahira N
Pancreatology; 2020 Sep; 20(6):1123-1130. PubMed ID: 32753119
[TBL] [Abstract][Full Text] [Related]
13. Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors.
Raimondi S; Maisonneuve P; Löhr JM; Lowenfels AB
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1894-7. PubMed ID: 17855711
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment.
van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG;
JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170
[TBL] [Abstract][Full Text] [Related]
15. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.
Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H
Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385
[TBL] [Abstract][Full Text] [Related]
16. Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?
Tsang ES; Topham JT; Karasinska JM; Lee MKC; Williamson LM; Mendis S; Denroche RE; Jang GH; Kalloger SE; Moore RA; Mungall AJ; Bathe OF; Tang PA; Notta F; Wilson JM; Laskin J; O'Kane GM; Knox JJ; Goodwin RA; Loree JM; Jones SJM; Marra MA; Gallinger S; Schaeffer DF; Renouf DJ
Clin Cancer Res; 2021 Jan; 27(1):246-254. PubMed ID: 32958704
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre.
Roselló S; Pizzo C; Huerta M; Muñoz E; Aliaga R; Vera A; Alfaro-Cervelló C; Jordá E; Garcés-Albir M; Roda D; Dorcaratto D; Tarazona N; Torondel S; Guijarro J; Sánchiz V; Gambardella V; Fleitas-Kanonnikoff T; Lluch P; Pascual I; Ferrández A; Sabater L; Cervantes A
ESMO Open; 2020 Nov; 5(6):e000929. PubMed ID: 33229503
[TBL] [Abstract][Full Text] [Related]
19. Early onset pancreatic cancer: a controlled trial.
Tingstedt B; Weitkämper C; Andersson R
Ann Gastroenterol; 2011; 24(3):206-212. PubMed ID: 24713777
[TBL] [Abstract][Full Text] [Related]
20. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
